Bis(2-phenylbiguanidium) adipate tetrahydrate

In the title salt, 2C8H12N5 +·C6H8O4 2−·4H2O, the anion is located on a centre of symmetry. The observed supramolecular network of the crystal structure is produced by ten different hydrogen bonds of the N—H⋯N, N—H⋯O and O—H⋯O types. One additional O—H group is not connected to an acceptor site.

[1]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[2]  J. McNeill,et al.  Vanadyl-biguanide complexes as potential synergistic insulin mimics. , 1999, Journal of inorganic biochemistry.

[3]  C. Sirtori,et al.  Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. , 1994, Pharmacological research.

[4]  Anthony L. Spek,et al.  Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[5]  Maria Cristina Burla,et al.  SIR92 – a program for automatic solution of crystal structures by direct methods , 1994 .

[6]  V. Parrino,et al.  Hypoglycemic Agents. II.1—3 Arylbiguanides , 1959 .

[7]  Z. Mic̆ka,et al.  Inorganic salts of biguanide Searching for new materials for second harmonic generation , 2008 .

[8]  S. Colowick,et al.  Methods in Enzymology , Vol , 1966 .

[9]  B. Clement,et al.  Characterization of biguanides by 15N NMR spectroscopy , 1999 .

[10]  E. Gulve,et al.  Chemistry and biochemistry of type 2 diabetes. , 2004, Chemical reviews.

[11]  R. Howells,et al.  A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil , 1987, The Journal of pharmacy and pharmacology.

[12]  良二 上田 J. Appl. Cryst.の発刊に際して , 1970 .

[13]  G. Sheldrick A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[14]  A. A. Pinkerton,et al.  Energetic Materials: the Biguanidium Nitrates , 1996 .

[15]  P. Vanĕk,et al.  Organic salts of biguanide – An attempt to crystal engineering of novel materials for second harmonic generation , 2010 .

[16]  M. Battell,et al.  Vanadium compounds as insulin mimics. , 1999, Metal ions in biological systems.

[17]  G. de Nanteuil,et al.  Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro. , 1994, Molecular pharmacology.

[18]  R. Rossi,et al.  Technetium(V) and rhenium(V) complexes of biguanide derivatives. Crystal structures , 1999 .

[19]  V. Parrino,et al.  Hypoglycemic Agents. I.1 Chemical Properties of β-Phenethylbiguanide.2 A New Hypoglycemic Agent3 , 1959 .